Open-angle glaucoma threatens the sight of more than 50 million people worldwide, with the number of annual cases significantly on the rise. This means glaucoma patients are an increasingly important part of any practice. Lumenis offers an array of ophthalmic laser systems that continue to provide the ophthalmologist with essential surgical tools to help lower intraocular pressure and control this progressive, degenerative disease.

A minimally invasive technological breakthrough, the Selecta Family of laser system is changing the future vision of glaucoma patients with Selective Laser Trabeculoplasty (SLT). SLT provides the benefits of Argon Laser Trabeculoplasty (ALT) without the coagulative damage that leads to scarring.
Lumenis’ family of advanced glaucoma lasers is invaluable mainstay in the treatment of glaucoma.